A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis
Clicks: 145
ID: 111103
This study demonstrated that topical imiquimod (TLR7 agonist) before intradermal hepatitis B vaccination was safe, with significantly better seroprotection than
| Reference Key |
fan-ngaiclinicala
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Hung, Ivan Fan-Ngai;Yap, Desmond Yat-Hin;Yip, Terence Pok-Siu;Zhang, Ricky Ruiqi;To, Kelvin Kai-Wang;Chan, Kwok-Hung;Tang, Sydney Chi-Wai;Lui, Sing-Leung;Levin, Yotam;Kochba, Efrat;Lau, Johnson Yiu-Nam;Yuen, Man-Fung;Chan, Tak-Mao;Yuen, Kwok-Yung; |
| Journal | clinical infectious diseases |
| Year | Year not found |
| DOI | DOI not found |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.